The USTR Special 301 Committee presented KEI with four questions in follow-up to our earlier comments. Below are the questions and KEI’s responses, also available as PDF: KEI-Responses-to-Hearing-Questions-2025-Special-301 KEI Responses to Hearing Questions – 2025 Special 301 Review (docket number… Continue Reading
Annually, the Office of the United States Trade Representative spearheads the Special 301 review process, whose goal is to produce a report that names-and-shames countries that have committed perceived offenses against intellectual property rights. The USTR solicits written comments from… Continue Reading
National policies and practices as regards the granting of and exceptions to patents, copyrights, and other types of intellectual property are often influenced by pressure from other countries. The United States is the most important source of pressure on intellectual… Continue Reading
Revised May 6, 2024 Against the backdrop of the tortuous negotiations among WHO Member States on technology transfer and know-how at the last mile of the pandemic agreement talks, on Wednesday, 1 May 2024, Switzerland offered a surprise amendment in… Continue Reading
This is an annex to the document: KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024, which is available as a PDF here: KEI.MutuallyAgreedTerms.A_INB_9_3Rev1.22April2024draft Annex on Investor-State Dispute… Continue Reading
On 15 April 2024, the World Trade Organization (WTO) published a document, IP/C/W/712, entitled, Review of the implementation of the TRIPS Agreement: Article 71.1; this date marks 30 years after the establishment of the WTO. Colombia’s proposal can be found… Continue Reading
These are KEI’s post hearing responses to three questions regarding USTR’s Special 301 list. KEI-Special301-28Feb2024 One question was a follow up to KEI’s testimony that USTR should develop a policy on the trade related aspects of biomedical R&D that does… Continue Reading
The 154th session of the World Health Organization’s (WHO) Executive Board will take place from 22 January 2024 to 27 January 2024 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading